Proteins & Tumor Markers Flashcards

1
Q

Electrophoresis

A
  • Movement of charged molecules/particles in a liquid medium under the influence of an electrical field
  • Used to separate proteins, mainly serum*, CSF, urine and hemoglobins
  • Sample applied at cathodic (-) end of alkaline gel and voltage applied –> negatively charged proteins migrate based on net charge/size
  • Proteins stained and visualized, quantified by densitometer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Electrophoresis Media

A
  • Most common is agarose gel –> polysaccharide from seaweed, neutral so separation based on mainly charge, low endosmosis
  • Polyacrylamide gel –> used in IEF & nucleic acid separation, not charged = no endosmosis, particles separated by size (crosslinking fibers), medium has neurotoxic monomers (issue if made in-house)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Electroendosmosis

A
  • Support has fixed negative charges (OH-) with adjacent immobile (+) ions –> Stern Potential
  • When voltage applied, solvent flows towards cathode
  • Mobile ions (Zeta Potential) with low to no-charge migrate with solvent toward cathode, strong negative charges ions remain fixed to medium (or migrate slowly)
  • Migration flow dependent on distance from fixed charges (less flow as farther away)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hemoglobin Electrophoresis

A
  • Run on both alkaline and acid gels to separate Hgb variants

ALKALINE: A / F / S,D,G / C,E,O,A2
ACID: F / A,D,G,O,A2,E / S / C

  • separation also done by HPLC or capillary electrophoresis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Capillary Electrophoresis

A
  • Process run in long capillary tube with each end in inlet/outlet buffer; spec (lamp&detector) set up to detect fractions
  • Good heat dissipation allows for very high voltage
  • Rapid separation, no staining or densitometry, highly automated
  • Very high endosmosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Isoelectric Focusing (IEF)

A
  • Ampholyte mixture buffer creates linear pH gradient along gel
  • Proteins migrate to isoelectric point (pI) = pH at which protein has no net charge
  • Refocusing of proteins that try to diffuse (due to gradient they are sent back to pI) allows for sharp bands
  • Used for CSF oligoclonal banding (MS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Western Blot

A
  • not used much clinically
  • proteins separated by MW in gel electrophoresis
  • transferred to nitro-cellulose membrane “blotting”
  • Sample Ab’s bind to immobilized target proteins, washed and stain using labeled Ab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Albumin

A
  • Only protein quantified by ep, others need nephelometry/turbidimetry
  • Most abundant protein in plasma (60%), maintains Colloid Osmotic Pressure (COP) and carrier for many molecules
  • Hyperalbuminemia: not significant other than dehydration
  • Hypoalbuminemia: increased loss (NEPHROTIC SYNDROME, gi, burns), decreased production (liver failure, malnutrition)
  • Analbuminemia (little to no albumin) and bisalbuminemia (two peaks, dimeric protein)
  • Being bound to bili/drugs may alter mobility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pre-Albumin

A
  • Not a form or precursor of albumin
  • Migrates before albumin on gel (seen in CSF gels, not always in serum gels)
  • aka Thyroxine-binding protein (TBPA), transthyretin
  • Sensitive marker of nutritional status (measured by neph/turb)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alpha 1 Proteins

A
  • A1-Antitrypsin (AAT): protease inhibitor that binds/inactivates trypsin, deficiency associated w/ pulmonary emphysema & neonatal hepatitis, SPEP screening needs IEF to determine phenotype (ZZ & SZ high risk)
  • A1-Acid Glycoprotein (AAG): APR, rarely measured
  • A1-Fetoprotein (AFP): main fetal plasma protein, measured in amniotic fluid/maternal serum to screen for fetal abnormalities (neural tube defect), hepatic tumor marker
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alpha 2 Proteins

A
  • A2-Macroglobulin (A2MG): Largest non-Ig, increased in nephrotic syndrome- replaces lost albumin to maintain COP (not cleared, increased synthesis in liver), rarely measured
  • Ceruloplasmin: Cu binding protein (8 Cu per molecule), plasma redox reactions (ferritin -> transferrin), screen for Wilson’s Dz
  • Haptoglobin: binds Hgb irreversibly in intravascular hemolysis to prevent Fe loss (or bacteria use), low levels indicate hemolytic dz
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Beta Proteins

A
  • Transferrin: Iron transport protein, increased in IDA (also pregnancy, estrogen therapy), decreased in inflammation/malignancy/liver dz, NEGATIVE APR
  • C3/C4 Complement Proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Complement Proteins

A
  • Classical Pathway (C1-C4): Immune complexes recognized by C1, C2/C4 activate C3 (MAC)
  • Alternative Pathway (C3, factor B/D, properdin): activated by bacteria, yeast, or endotoxins –> foreign surfaces
  • C3 in both pathways, C4 classic only
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Complement Deficiency

A
  • C2/C4**: Autoimmune Dz
  • C3**: infection, encapsulated bacteria; low in all complement situations
  • C5-C9: persistent Neisseria infection
  • C1 Inhibitor: Hereditary Angioedema (HAE)–> can cause subcutaneous edema in laryngeal/bronchial/GI tissues, can be life-threatening, low C4
  • CH50 = Total complement assay not preferred as large individual deficiencies may not be detected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Immunoglobulins

A
  • IgG: 2 heavy chains + 2 light chains, produced by plasma cells, long term immunity (or chronic dz), crosses placenta
  • IgM: pentamer linked by J peptides, produced by plasma cells as first-line immunity and persists for 6-12months (acute dz)
  • IgA: monomer or dimer, circulatory and secretory (tears, sweat, saliva etc), cleared by liver
    NOT ON SPEP:
  • IgE: allergies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hypergammaglobulinemia

A
  • Polyclonal: increase in multiple ig’s, seen as B-G smear on SPEP, IgG most obvious
  • Monoclonal: single clone of plasma cells proliferates and produces single Ig (paraprotein or M-protein)
17
Q

Monoclonal Gammopathies

A
  • Multiple Myeloma (60% of MGs)
  • B-cell Lymphocytes (15%): Lymphoma, CLL
  • Waldenstrom’s macroglobulinemia (IgM): hyperviscosity, Bence-Jones proteins
  • MG of Undetermined Significance (MGUS): small MG w/o clinical symptoms, can progress in time and should be monitored
  • Non-secretory MM: Multiple Myeloma that doesn’t produce Ig (detect by diff method)
  • Serum Free Light Chains: deviate from 2:1 (K:L) ratio can indicate MG
18
Q

Multiple Myeloma

A
  • Plasma cell malignancy, one or more clones (mainly IgG)
    Commonly diffuse marrow distribution:
  • Plasmacytoma: solitary tumor
  • Pancytopenia
  • Osteolytic bone lesions: pain, fractures, breakdown by plasma cells
  • Bence-Jones proteins found in urine (precipitates at 40-60C, re-dissolves at 100C)
19
Q

Cryoglobulins

A

Proteins that reversibly precipitate in temps below body temperature
Incubate at 4’ –> if precipitate forms and redissolves at 37’ –> Cryoglobulins are present

20
Q

Acute Phase Reactants (APR) + SPEP Pattern

Immediate response

A

Proteins whose concentration increase or decrease by >50% in response to tissue injury/inflammation/malignancy

  • Positive APR: C3, C4, CRP, AAT, A2MG, Hpt, Fibrinogen
  • Negative APR: Albumin, Pre-albumin, Trf

SPEP PATTERN:

  • Albumin decrease (- APR)
  • A2 increase due to Haptoglobin (+ APR)
21
Q

Delayed Response SPEP

A
  • Albumin decreased (- APR)
  • Haptoglobin increase (+ APR)
  • Gamma globulin increase (Ab response)
22
Q

Nephrotic Syndrome SPEP

A
  • Albumin decreases (renal loss)
  • A2 increase (A2MG replacement of albumin)
  • Gamma globulin decrease
23
Q

Hepatic Cirrhosis SPEP

A
  • Albumin decreases (impaired synthesis)

- Beta-Gamma Bridging, Increased polyclonal gamma globulin (IgA increase, low hepatic clearing)

24
Q

Split-Beta SPEP

A

Separat ion of beta peak into two bands

  • B1 = Transferring
  • B2 = Complement C3
25
Q

Monoclonal Gammopathy SPEP

A
  • Mild albumin decrease
  • Sharp increase in gamma region –> IgA MG may be seen as a sharp beak in A2/B region rather than gamma
  • Beware of fibrinogen band in Beta region, can be mistaken for MG
26
Q

Immunoelectrophoresis (IEF)

A
  • Not commonly used anymore
  • Sample added to cells in middle of gel, in between troughs
  • Antisera to antigens of interest added to troughs
  • If antigen is present in sample, precipitant arc will form in zone of equivalence after electrophoresis
  • Thick and bulged arc indicates a positive reaction –> subjective and difficult to interpret
27
Q

Immunofixation (IFE)

A
  • Gel prepared to identify monoclonal gammopathies and light chain presence (G, A, M, Kappa, Lambda)
  • Sample applied to slots and allowed to electrophorese, G/A/M/K/L antisera added to corresponding rows and allowed to precipitate
  • Gel is stained and dried
  • Positive gammopathy is where band is present in G/A/M and corresponding band in K/L (Ex. IgG - Kappa gammopathy)
  • Possible to have biclonal or polyclonal gammopathies
28
Q

Tumor Markers

A
  • A substance produced by a tumor found in blood, body fluids, or tissue that may be used to predict the presence and size of the tumor, and/or monitor response to therapy
  • Ideally, but not realistically useful in screening/diagnosis
  • Main applications: predicting therapeutic response, detecting recurrence, monitoring treatment
29
Q

Prostate-Specific Antigen (PSA)

A
  • Enzyme tumor marker fairly specific to prostate tissue (hormonally regulated tissue, may be seen in breast)
  • Exists free & bound to ACT & A2MG proteins
  • Measurement enhancements –> age related reference intervals, PSA density (corrects for prostate volume), PSA velocity (change over time), Free PSA
    • PSA not considered to save lives, but enhanced measurements may be more clinically significant
30
Q

Human Chorionic Gonadotropin (hCG)

A
  • Hormone secreted by placenta during pregnancy (alpha proteins in early preg, beta in late); also seen in multiple tumor types
  • Trophoblastic tumors: choriocarcinoma, hCG correlates well w/tumor volume, after surgery/chemo need hCG follow up yearly
  • Phantom hCG: persistent low levels of hCG that can be due to residual tumor/HAMA,HAAA/heterophile Ab, doesn’t show in urine hCG
  • Assays: “Intact” measure alpha:beta dimer only, “Total” measure alpha:beta plus free beta (preferred for tumors, secrete more beta)
31
Q

Oncofetal Antigens

A

Proteins produced during fetal life that decline or disappear at birth. They can reappear with cancer due to re-activation of transcription.

ex: AFP, CEA

32
Q

Alpha-Fetoprotein (AFP)

A
  • Major fetal plasma protein, increased in maternal serum during 3rd trimester
  • Increased in liver disease, hepatocellular carcinoma (HCC, hepatoma) –> level correlates w/ tumor burden, useful in monitoring treatment
  • With hCG, useful in classifying germ cell tumors (ie. Lance Armstrong had embryonal carc.)
33
Q

Carcinoembryonic Antigen (CEA)

A
  • Heterogenous glycoprotein in family of 36 proteins (10 genes)
  • Elevated in many cancer types (Colorectal, GI, Panc, Lung, Breast/Ovarian/Uterine)
  • Also elevated in non-cancerous conditions such as liver dz, IBD, pancreatitis
  • Unlike hCG & AFP, levels correlate poorly with tumor burden
34
Q

CA 15-3, CA 27.29

A
  • Breast cancer markers (23%) but elevated in many other cancers, not good for screening
  • Better for following dz/treatment: 25% increase is significant, increase may be due to tumor lysis in effective treatment
    Assays:
  • CA 15-3: dual monoclonal sandwich assay
  • CA 27.29: single monoclonal assay
  • Results are comparable but more information on CA 15-3
35
Q

CA-125

A
  • Marker for ovarian cancer: 50% S1, 90% S2, >90% S3/S4
  • Also elevated in other cancers: endometrial, pancreatic, lung, breast, colorectal
  • Not useful for screening due to non-specificity
  • Can predict recurrent 2-3 mo before clinical symptoms
36
Q

Other tumor markers

A
  • Blood group antigens CA 19-9 & CA 72-4: Sialylated Lewis antigen & marker for pancreatic/colorectal cancer (19-9), not often used
  • Immunoglobulins: markers of Multiple Myeloma
  • Thyroglobulin: differentiated thyroid cancer, used to follow regeneration of thyroid tissue (not wanted following radiation)
  • Chromogranin A: pheochromocytoma (adrenal medullary tumor)